ARCHIVES

New Drugs Improve Outlook For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

DCPC Faces Huge Out Year Costs Of Four Trials

February 15, 1991

NCI Advisory Group, Other Cancer Meetings For Sept,. Oct,. Future

August 25, 1989

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977